Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

The Study Of CT Scans and Echo Parameters in Patients With PAH

This study has been completed.
Information provided by (Responsible Party):
Northwell Health Identifier:
First received: February 20, 2008
Last updated: July 29, 2013
Last verified: July 2013
Current standard of the diagnosis and monitoring of PHNT requiring combination of invasive and non-invasive tests. The goal of the study is to correlate data from CT scans, echocardiograms, right heart catheterization, PFTs, sleep studies, and perfusion scans. The ultimate goal is to determine patterns of the PAH disease processes.

Pulmonary Hypertension

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Study of CT Scan and Echocardiogram Parameters in Patients With Pulmonary Hypertension With Regards to Hemodynamics, Sleep Studies, and Various Laboratory Markers.

Resource links provided by NLM:

Further study details as provided by Northwell Health:

Primary Outcome Measures:
  • The Study Of CT Scans and Echo Parameters in Patients With PAH [ Time Frame: All data has been previously collected. ]
    Correlation of Pulmonary artery diameter as measured by CT scan and Pulmonary artery systolic pressure as measured by Echocardiogram.

Enrollment: 71
Study Start Date: April 2007
Study Completion Date: July 2011
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
I=Pulmonary Hypertension Patients A=ILD patients with Pulmonary Hypertension Patients

Detailed Description:
The goal of our study is to correlate data from various non-invasive tests such as commuted tomography (CT) imaging, echocardiogram, Pulmonary Function Tests, and other laboratory tests along with hemodynamic measurements from Right Heart Catheterizations in these ILD patients with Pulmonary Hypertension, as well as all other pulmonary hypertension. The ultimate goal is to determine patterns of the PAH disease processes, as well as define optimal diagnostic modalities including in-hospital verses outpatient studies.

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Pulmonary Arterial Hypertension; Idiopathic Lung Disease

Inclusion Criteria:

  • Pulmonary Hypertension;
  • ILD with Pulmonary Hypertension

Exclusion Criteria:

  • NON-PH
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00625963

United States, New York
North Shore-Long Island Jewish Health System
New Hyde Park, New York, United States, 11040
Sponsors and Collaborators
Northwell Health
Principal Investigator: Arunabh Talwar, MD Northwell Health
  More Information

Responsible Party: Northwell Health Identifier: NCT00625963     History of Changes
Other Study ID Numbers: 07.060
Study First Received: February 20, 2008
Last Updated: July 29, 2013

Keywords provided by Northwell Health:
Pulmonary Hypertension;
CT Imaging;
Hemodynamic measurements of RHC.
Pulmonary Function Tests

Additional relevant MeSH terms:
Hypertension, Pulmonary
Vascular Diseases
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases processed this record on May 22, 2017